Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways.
Open accessAbstract
Transcription of the prostate-specific antigen (PSA) gene escapes regulation by androgens in advanced prostate cancer. To determine the molecular mechanism(s) of androgen-independent regulation of the PSA gene, the possibility that the androgen receptor (AR) is activated in the absence of androgen by stimulation of protein kinase A (PKA) was investigated. Activation of PKA by forskolin resulted in elevated expression of the PSA gene in androgen-depleted LNCaP cells, an effect that was blocked by the antiandrogen, bicalutamide. Further evidence that induction of PSA gene expression was dependent on AR was obtained from experiments using PC3 cells devoid of AR. Neither PSA, PB, nor ARR3 androgen-responsive reporters could be induced by activation of PKA in the absence of transfected AR. In addition, when nuclear AR from forskolin-treated LNCaP cells was incubated with oligonucleotides encoding an androgen response element of the PSA promoter and examined by electromobility shift assay, an increase in AR-androgen response element complex formation was observed. Lastly, cotransfection of an expression vector for a chimeric protein encoding the amino-terminal domain of the human AR linked to Gal4 and a 5xGal4UAS reporter gene construct resulted in activation of the amino-terminal domain of the AR by stimulation of PKA activity. These results demonstrate androgen-independent induction of PSA gene expression in prostate cancer cells by an AR-dependent pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
When prostate cancer cells are treated with forskolin, AR-driven transcription is increased from AR-responsive promoters, an effect quenched by the addition of AR antagonists bicalutamide and flutamide.
“When prostate cancer cells are treated with the inhibitor forskolin (a naturally derived molecule that activates adenylyl cyclase, thus increasing the intracellular levels of cAMP and consequently protein kinase A), AR-driven transcription is increased from ARresponsive promoters, an effect that is quenched by the addition of AR antagonists bicalutamide and flutamide (55,56).”
From Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer (2011) · cites this paper as [56]
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · see citing works
Veldscholte, J., Ris‐Stalpers, C., Kuiper, G. G. J. M., Jenster, G. W., Berrevoets, C., Claassen, E., van Rooij, H. C. J., Trapman, J., Brinkmann, A. O., & Mulder, E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80067-1 · Cited by 945 · see citing works
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938 · see citing works
Jenster, G., van der Korput, H. A. G. M., van Vroonhoven, C., van der Kwast, T. H., Trapman, J., & Brinkmann, A. O. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1396 · Cited by 523 · see citing works
Aronica, S. M., & Katzenellenbogen, B. S. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.6.7689695 · Cited by 455 · see citing works
The Promoter of the Prostate-Specific Antigen Gene Contains a Functional Androgen Responsive Element
Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Brinkmann, A. O., & Trapman, J. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1921 · Cited by 448 · see citing works
Veldscholte, J., Berrevoets, C., Ris‐Stalpers, C., Kuiper, G. G. J. M., Jenster, G. W., Trapman, J., Brinkmann, A. O., & Mulder, E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90401-4 · Cited by 442 · see citing works
Kemppainen, J., Lane, M. V., Sar, M., & Wilson, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48380-9 · Cited by 430 · see citing works
Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth, L. V., & Weigel, N. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19900 · Cited by 429 · see citing works
Jenster, G., van der Korput, H. A. G. M., Trapman, J., & Brinkmann, A. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7341 · Cited by 419 · see citing works
Cleutjens, K. B. J. M., Eekelen, C. C. E.-V., van der Korput, H. A. G. M., Brinkmann, A. O., & Trapman, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6379 · Cited by 408 · see citing works
Steroid hormone receptors and their regulation by phosphorylation
Weigel, N. L. (1996) · Biochemical Journal · doi:10.1042/bj3190657 · Cited by 351 · see citing works
Ignar-Trowbridge, D. M., Teng, C. T., Ross, K. A., Parker, M. G., Korach, K. S., & McLachlan, J. A. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.8.8232319 · Cited by 325 · see citing works
Wilson, E. M., & French, F. S. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33103-4 · Cited by 312 · see citing works
Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer
Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H., & Henderson, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7043 · Cited by 302 · see citing works
Veldscholte, J., Berrevoets, C., Brinkmann, A. O., Grootegoed, J. A., & Mulder, E. (1992) · Biochemistry · doi:10.1021/bi00123a026 · Cited by 278 · see citing works
Ignar-Trowbridge, D. M., Pimentel, M. A., Parker, M. G., McLachlan, J. A., & Korach, K. S. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612509 · Cited by 230 · see citing works
Aronica, S. M., & Katzenellenbogen, B. S. (1991) · Endocrinology · doi:10.1210/endo-128-4-2045 · Cited by 203 · see citing works
Sato, N., Sadar, M. D., Bruchovsky, N., Saatcioglu, F., Rennie, P. S., Sato, S., Lange, P. H., & Gleave, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17485 · Cited by 202 · see citing works
Self-citationStructural determinants of DNA-binding specificity by steroid receptors
Zilliacus, J., Wright, A. P. H., Carlstedt‐Duke, J., & Gustafsson, J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659083 · Cited by 199 · see citing works
Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation
Ikonen, T., Palvimo, J. J., Kallio, P. J., Reinikainen, P., & Jänne, O. A. (1994) · Endocrinology · doi:10.1210/endo.135.4.7925097 · Cited by 187 · see citing works
Identification of three proline-directed phosphorylation sites in the human androgen receptor
Zhou, Z. X., Kemppainen, J., & Wilson, E. M. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.5.7565807 · Cited by 186 · see citing works
Sato, N., Gleave, M. E., Bruchovsky, N., Rennie, P. S., Goldenberg, S. L., Lange, P. H., & Sullivan, L. D. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(96)00018-0 · Cited by 183 · see citing works
Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor
El‐Tanani, M., & Green, C. D. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.7.9939 · Cited by 165 · see citing works
Kuil, C. W., Berrevoets, C., & Mulder, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27569 · Cited by 130 · see citing works
Characterization of the gene for prostate-specific antigen, a human glandular kallikrein
Lundwall, Å. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91362-4 · Cited by 114 · see citing works
Chamberlain, N. L., Whitacre, D. C., & Miesfeld, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26772 · Cited by 113 · see citing works
The unliganded estrogen receptor (ER) transduces growth factor signals
Newton, C. J., Buric, R., Trapp, T., Brockmeier, S. J., Pagotto, U., & Stalla, G. K. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90197-x · Cited by 111 · see citing works
Palvimo, J. J., Kallio, P. J., Ikonen, T., Mehto, M., & Jänne, O. A. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114755 · Cited by 92 · see citing works
TURGEON, J. L., & Waring, D. W. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.7.7984148 · Cited by 92 · see citing works
ZOPPI, S., Wilson, C. M., Harbison, M. D., Griffin, J. E., Wilson, J. D., McPhaul, M. J., & Marcelli, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116269 · Cited by 91 · see citing works
Forskolin-Induced Dephosphorylation of the Androgen Receptor Impairs Ligand Binding
Blok, L. J., de Ruiter, P. E., & Brinkmann, A. O. (1998) · Biochemistry · doi:10.1021/bi9724422 · Cited by 86 · see citing works
Antras, J., Lasnier, F., & Pairault, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35296-1 · Cited by 85 · see citing works
van Laar, J. H., Berrevoets, C., Trapman, J., Zegers, N. D., & Brinkmann, A. O. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67856-7 · Cited by 83 · see citing works
Acrosin biosynthesis in meiotic and postmelotic spermatogenic cells
Kashiwabara, S., Arai, Y., Kodaira, K., & Baba, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81047-2 · Cited by 80 · see citing works
Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor
Kuiper, G. G. J. M., de Ruiter, P. E., Trapman, J., Boersma, W. J. A., Grootegoed, J. A., & Brinkmann, A. O. (1993) · Biochemical Journal · doi:10.1042/bj2910095 · Cited by 65 · see citing works
Berrevoets, C., Veldscholte, J., & Mulder, E. A. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90313-l · Cited by 63 · see citing works
Androgen Receptor Phosphorylation
Blok, L. J., de Ruiter, P. E., & Brinkmann, A. O. (1996) · Endocrine Research · doi:10.3109/07435809609030508 · Cited by 62 · see citing works
Kuiper, G. G. J. M., & Brinkmann, A. O. (1995) · Biochemistry · doi:10.1021/bi00006a005 · Cited by 59 · see citing works
Andrews, P. E., Young, C. Y. F., Montgomery, B. T., & Tindall, D. J. (1992) · PubMed · Cited by 51 · see citing works
Differential transactivation by the androgen receptor in prostate cancer cells
Snoek, R., Bruchovsky, N., Kasper, S., Matusik, R. J., Gleave, M. E., Sato, N., Mawji, N. R., & Rennie, P. S. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980901)36:4 · Cited by 50 · see citing works
Phosphorylation of the androgen receptor by a nuclear cAMP-independent protein kinase
Goueli, S. A., Holtzman, J. L., & Ahmed, K. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90297-3 · Cited by 44 · see citing works
Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides
Snoek, R., Rennie, P. S., Kasper, S., Matusik, R. J., & Bruchovsky, N. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00116-1 · Cited by 41 · see citing works
Picard, D., Bunone, G., Liu, J. W., & Donzé, O. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250597 · Cited by 30 · see citing works
Kuiper, G. G. J. M., de Ruiter, P. E., & Brinkmann, A. O. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90407-a · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sun, S., Sprenger, C. C. T., Vessella, R. L., Haugk, K., Soriano, K., Mostaghel, E. A., Page, S. T., Coleman, I. M., Nguyen, H. M., Sun, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41824 · Cited by 748 · see citing works
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568 · see citing works
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
Grossmann, M. E., Huang, H., & Tindall, D. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1687 · Cited by 548 · see citing works
Androgen receptor signaling in prostate cancer development and progression
Tindall, D. J., & Lonergan, P. E. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.83937 · Cited by 544 · see citing works
Andersen, R. J., Mawji, N. R., Wang, J., Wang, G., Haile, S., Myung, J.-K., Watt, K., Tam, T., Yang, Y. C., Bañuelos, C. A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.027 · Cited by 503 · see citing works
Self-citationNon-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493 · see citing works
Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer
Signoretti, S. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1918 · Cited by 397 · see citing works
Zegarra-Moro, O. L., Schmidt, L. J., Huang, H., & Tindall, D. J. (2002) · PubMed · Cited by 395 · see citing works
Ueda, T., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108255200 · Cited by 381 · see citing works
Self-citationAndrogen Receptor Phosphorylation
Gioeli, D. G., Ficarro, S. B., Kwiek, J. J., Aaronson, D. S., Hancock, M., Catling, A. D., White, F. M., Christian, R. E., Settlage, R. E., Shabanowitz, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204131200 · Cited by 355 · see citing works
Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer
Borgoño, C. A., Michael, I. P., & Diamandis, E. P. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.257.2.5 · Cited by 340 · see citing works
Mechanisms of the androgen receptor splicing in prostate cancer cells
Liu, L. L., Xie, N., Sun, S., Plymate, S. R., Mostaghel, E. A., & Dong, X. (2013) · Oncogene · doi:10.1038/onc.2013.284 · Cited by 313 · see citing works
Ueda, T., Mawji, N. R., Bruchovsky, N., & Sadar, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203313200 · Cited by 311 · see citing works
Self-citationAn androgen receptor N-terminal domain antagonist for treating prostate cancer
Myung, J., Banuelos, C. A., Fernandez, J. G., Mawji, N. R., Wang, J., Tien, A. H., Yang, Y. C., Tavakoli, I., Haile, S., Watt, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66398 · Cited by 307 · see citing works
Self-citationOettgen, P., Finger, E., Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, A., Brown, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1216 · Cited by 268 · see citing works
Androgen receptor as a target in androgen-independent prostate cancer
Balk, S. P. (2002) · Urology · doi:10.1016/s0090-4295(02)01593-5 · Cited by 264 · see citing works
Chmelar, R. S., Buchanan, G., Need, E. F., Tilley, W. D., & Greenberg, N. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.22365 · Cited by 256 · see citing works
Androgen Receptor Structural and Functional Elements: Role and Regulation in Prostate Cancer
Dehm, S. M., & Tindall, D. J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0223 · Cited by 252 · see citing works
Androgen Receptor Variants Occur Frequently in Castration Resistant Prostate Cancer Metastases
Zhang, X., Morrissey, C. M., Sun, S., Ketchandji, M., Nelson, P. S., True, L. D., Vakar‐Lopez, F., Vessella, R. L., & Plymate, S. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027970 · Cited by 240 · see citing works
Caveolin-1 Interacts with Androgen Receptor
Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., & Richie, J. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006598200 · Cited by 239 · see citing works
Sastry, K. S., Karpova, Y., Prokopovich, S., Smith, A. J., Essau, B., Gersappe, A., Carson, J. P., Weber, M. J., Register, T. C., Chen, Y. Q., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611370200 · Cited by 225 · see citing works
Behavioral stress accelerates prostate cancer development in mice
Hassan, S., Karpova, Y., Baiz, D., Yancey, D., Pullikuth, A., Flores, A., Register, T. C., Cline, J. M., D’Agostino, R., Danial, N. N., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63324 · Cited by 231 · see citing works
Lazennec, G., Canaple, L., Saugy, D., & Wahli, W. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0575 · Cited by 220 · see citing works
Is the Achilles’ Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling?
Litvinov, I. V., Marzo, A. M. D., & Isaacs, J. T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022038 · Cited by 215 · see citing works
Mechanisms mediating androgen receptor reactivation after castration
Yuan, X., & Balk, S. P. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.03.021 · Cited by 204 · see citing works
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Chen, S., Xu, Y., Yuan, X., Bubley, G. J., & Balk, S. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604193103 · Cited by 202 · see citing works
Role of SRC-1 in the Promotion of Prostate Cancer Cell Growth and Tumor Progression
Agoulnik, I. U., Vaid, A., Bingman, W. E., Erdeme, H., Frolov, A., Smith, C. S., Ayala, G., Ittmann, M., & Weigel, N. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3541 · Cited by 201 · see citing works
Bakin, R. E., Gioeli, D. G., Sikes, R. A., Bissonette, E. A., & Weber, M. J. (2003) · PubMed · Cited by 201 · see citing works
Michels, G., & Hoppe, U. C. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.004 · Cited by 198 · see citing works
Dubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197 · see citing works
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188 · see citing works
Lee, L., Guan, J., Qiu, Y., & Kung, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8385-8397.2001 · Cited by 184 · see citing works
Androgen action and metabolism in prostate cancer
Green, S. M., Mostaghel, E. A., & Nelson, P. S. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.046 · Cited by 182 · see citing works
Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model
Igawa, T., Lin, F., Lee, M., Karan, D., Batra, S. K., & Lin, M. (2002) · The Prostate · doi:10.1002/pros.10054 · Cited by 181 · see citing works
Stress Kinase Signaling Regulates Androgen Receptor Phosphorylation, Transcription, and Localization
Gioeli, D. G., Black, B. E., Gordon, V. L., Spencer, A., Kesler, C. T., Eblen, S. T., Paschal, B. M., & Weber, M. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0351 · Cited by 175 · see citing works
Hansen, J., Zhang, H., Rasmussen, T. H., Petersen, R., Flindt, E., & Kristiansen, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005567200 · Cited by 187 · see citing works
Lin, D., Whitney, M. C., Yao, Z., & Keller, E. T. (2001) · PubMed · Cited by 169 · see citing works
Chesire, D. R., Ewing, C. M., Gage, W. R., & Isaacs, W. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205352 · Cited by 160 · see citing works
Yong, W., Yang, Z., Periyasamy, S., Chen, H., Yucel, S., Li, W., Lin, L. Y., Wolf, I. M., Cohn, M. J., Baskin, L. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609360200 · Cited by 156 · see citing works
Alterations of androgen receptor in prostate cancer
Linja, M. J., & Visakorpi, T. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.012 · Cited by 151 · see citing works
Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
Leung, J. K., & Sadar, M. D. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00002 · Cited by 152 · see citing works
Self-citationWinters, S. J., Brufsky, A., Weissfeld, J. L., Trump, D. L., Dyky, M. A., & Hadeed, V. (2001) · Metabolism · doi:10.1053/meta.2001.26714 · Cited by 152 · see citing works
Minireview: Alternative Activation Pathways for the Androgen Receptor in Prostate Cancer
Lamont, K. R., & Tindall, D. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0469 · Cited by 150 · see citing works
Ras signaling in prostate cancer progression
Weber, M. J., & Gioeli, D. G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10683 · Cited by 148 · see citing works
Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity
Sadar, M. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can_10-3398 · Cited by 147 · see citing works
Self-citationThe Amino Terminus of the Human AR Is Target for Corepressor Action and Antihormone Agonism
Dotzlaw, H., Moehren, U., Mink, S., Cato, A. C. B., Iñiguez-Lluhı́, J. A., & Baniahmad, A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0798 · Cited by 143 · see citing works
Gregory, C. W., Whang, Y. E., McCall, W., Fei, X., Liu, Y., Ponguta, L. A., French, F. S., Wilson, E. M., & Earp, H. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1158 · Cited by 140 · see citing works
Androgen Receptor Cross-talk with Cell Signalling Pathways
Čulig, Z. (2004) · Growth Factors · doi:10.1080/08977190412331279908 · Cited by 137 · see citing works
Denmeade, S. R., Sokoll, L. J., Dalrymple, S. L., Rosen, D. M., Gady, A. M., Bruzek, D. J., Ricklis, R. M., & Isaacs, J. T. (2003) · The Prostate · doi:10.1002/pros.10199 · Cited by 136 · see citing works
The Endocrinology of Prostate Cancer
Taplin, M. E., & Ho, S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7782 · Cited by 130 · see citing works
Cheng, H., Snoek, R., Ghaidi, F., Cox, M., & Rennie, P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0028 · Cited by 127 · see citing works
Flowers, L. O., Subramaniam, P. S., & Johnson, H. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208437 · Cited by 125 · see citing works
Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic
Eder, I. E., Čulig, Z., Putz, T., Nessler‐Menardi, C., Bartsch, G. H., & Klocker, H. (2001) · European Urology · doi:10.1159/000049782 · Cited by 122 · see citing works
Zhang, L., Adams, J. Y., Billick, E., Ilagan, R., Iyer, M. R., Le, K., Smallwood, A., Gambhir, S. S., Carey, M., & Wu, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0551 · Cited by 117 · see citing works
Signal transduction in prostate cancer progression
Gioeli, D. G. (2005) · Clinical Science · doi:10.1042/cs20040329 · Cited by 116 · see citing works
Edwards, J., & Bartlett, J. M. S. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05527.x · Cited by 118 · see citing works
G Proteins in Cancer: The Prostate Cancer Paradigm
Daaka, Y. (2004) · Science s STKE · doi:10.1126/stke.2162004re2 · Cited by 117 · see citing works
Androgen receptor and its splice variants in prostate cancer
Haile, S., & Sadar, M. D. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0766-7 · Cited by 113 · see citing works
Self-citationAberrant activation of the androgen receptor by NF-κB2/p52 in prostate cancer cells.
Nadiminty, N., Lou, W., Sun, M., Chen, J., Yue, J., Kung, H.-J., Evans, C. P., Zhou, Q., & Gao, A. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3703 · Cited by 113 · see citing works
Yang, Y. C., Banuelos, C. A., Mawji, N. R., Wang, J., Kato, M., Haile, S., McEwan, I. J., Plymate, S. R., & Sadar, M. D. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2901 · Cited by 108 · see citing works
Self-citationEder, I. E., Hoffmann, J., Rogatsch, H., Schäfer, G., Zopf, D., Bartsch, G. H., & Klocker, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700416 · Cited by 107 · see citing works
Pathophysiologic interactions in skeletal metastasis
Orr, F. W., Lee, J., Duivenvoorden, W., & Singh, G. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+ · Cited by 79 · see citing works
Merkle, D., & Hoffmann, R. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.017 · Cited by 104 · see citing works
Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors
Wu, L., Matherly, J., Smallwood, A., Adams, J. Y., Billick, E., Belldegrun, A. S., & Carey, M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301549 · Cited by 104 · see citing works
Asim, M., Siddiqui, I. A., Hafeez, B. B., Baniahmad, A., & Mukhtar, H. (2008) · Oncogene · doi:10.1038/sj.onc.1211016 · Cited by 101 · see citing works
Li, Y., Wang, L., Zhang, M., Melamed, J., Liu, X., Reiter, R. E., Wei, J., Peng, Y., Zou, X., Pellicer, À., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3380 · Cited by 101 · see citing works
An evaluation of bicalutamide in the treatment of prostate cancer
Schellhammer, P. F. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.9.1313 · Cited by 100 · see citing works
Wang, L., Lin, H.-K., Hu, Y., Xie, S., Yang, L., & Chang, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313963200 · Cited by 95 · see citing works
Ponnusamy, S., Coss, C. C., Thiyagarajan, T., Watts, K., Hwang, D., He, Y., Selth, L. A., McEwan, I. J., Duke, C. B., Pagadala, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0976 · Cited by 95 · see citing works
Lazier, C. B., Thomas, L. N., Douglas, R. C., Vessey, J. P., & Rittmaster, R. S. (2003) · The Prostate · doi:10.1002/pros.10340 · Cited by 94 · see citing works
X chromosome gene expression in human tissues: Male and female comparisons
Talebizadeh, Z., Simon, S. D., & Butler, M. G. (2006) · Genomics · doi:10.1016/j.ygeno.2006.07.016 · Cited by 92 · see citing works
A magic drug target: Androgen receptor
Li, D., Zhou, W., Pang, J., Tang, Q., Zhong, B., Shen, C., Li, X., & Hou, T. (2018) · Medicinal Research Reviews · doi:10.1002/med.21558 · Cited by 87 · see citing works
Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries
Romanuik, T. L., Wang, G., Holt, R. A., Jones, S. J. M., Marra, M. A., & Sadar, M. D. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-476 · Cited by 88 · see citing works
Self-citationLogan, I. R., Gaughan, L., McCracken, S. R., Sapountzi, V., Leung, H. Y., & Robson, C. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00147-06 · Cited by 88 · see citing works
Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
Imamura, Y., & Sadar, M. D. (2016) · International Journal of Urology · doi:10.1111/iju.13137 · Cited by 86 · see citing works
Self-citationBrown, R. S. D., Edwards, J., Doǧan, A., Payne, H. A., Harland, S. J., Bartlett, J. M. S., & Masters, J. R. (2002) · The Journal of Pathology · doi:10.1002/path.1206 · Cited by 87 · see citing works
Androgen receptor decoy molecules block the growth of prostate cancer.
Quayle, S. N., Mawji, N. R., Wang, J., & Sadar, M. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606718104 · Cited by 84 · see citing works
Self-citationThe Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity
Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y.-G., Gioeli, D. G., Weber, M. J., & Pestell, R. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313466200 · Cited by 83 · see citing works
Dong, Z., Liu, Y., Lu, S., Wang, A. Y., Lee, K., Wang, L., Revelo, M. P., & Lu, S. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0048 · Cited by 82 · see citing works
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
Wang, G., Jones, S. J. M., Marra, M. A., & Sadar, M. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209715 · Cited by 81 · see citing works
Self-citationSCHRADER, T. J. (2000) · Toxicological Sciences · doi:10.1093/toxsci/53.2.278 · Cited by 81 · see citing works
Calcium/calmodulin-dependent kinase II plays an important role in prostate cancer cell survival
Rokhlin, O. W., Taghiyev, A. F., Bayer, K. U., Bumcrot, D. A., Koteliansky, V., Glover, R. A., & Cohen, M. B. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.3975 · Cited by 79 · see citing works
Link, K. A., Balasubramaniam, S., Sharma, A. M., Comstock, C. E. S., Godoy‐Tundidor, S., Powers, N., Cao, K. H., Haelens, A., Claessens, F., Revelo, M. P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6392 · Cited by 79 · see citing works
Bonham, M. J., Arnold, H., Montgomery, B., & Nelson, P. S. (2002) · PubMed · Cited by 79 · see citing works
Yeung, F., Li, X., Ellett, J. D., Trapman, J., Kao, C. H., & Chung, L. W. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002755200 · Cited by 78 · see citing works
Davis, J. N., Küçük, Ö., & Sarkar, F. H. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10053 · Cited by 76 · see citing works
Sadar, M. D., & Gleave, M. E. (2000) · PubMed · Cited by 74 · see citing works
Self-citationMeimetis, L. G., Williams, D. E., Mawji, N. R., Banuelos, C. A., Lal, A., Park, J. J., Tien, A. H., Fernandez, J. G., de Voogd, N. J., Sadar, M. D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014056 · Cited by 71 · see citing works
Self-citationLee, S. O., Lou, W., Hou, M., Oñate, S. A., & Gao, A. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206735 · Cited by 71 · see citing works
Kim, D., Gregory, C. W., French, F. S., Smith, G. J., & Mohler, J. L. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64365-9 · Cited by 71 · see citing works
Specificity of cyclin D1 for androgen receptor regulation.
Petre, C. E., Cook, S. L., Burd, C. J., Marshall, T. W., Wetherill, Y. B., & Knudsen, K. E. (2003) · PubMed · Cited by 71 · see citing works
Cinar, B., Koeneman, K. S., Edlund, M., Prins, G. S., Zhau, H. E., & Chung, L. W. K. (2001) · PubMed · Cited by 69 · see citing works
Blaszczyk, N., Masri, B. A., Mawji, N. R., Ueda, T., McAlinden, G., Duncan, C. P., Bruchovsky, N., Schweikert, H.-U., Schnabel, D., Jones, E. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0974-3 · Cited by 66 · see citing works
Self-citationBeyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors
Caboni, L., & Lloyd, D. G. (2012) · Medicinal Research Reviews · doi:10.1002/med.21275 · Cited by 64 · see citing works
Rigas, A. C., Ozanne, D. M., Neal, D. E., & Robson, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306219200 · Cited by 64 · see citing works
Banuelos, C. A., Tavakoli, I., Tien, A. H., Caley, D. P., Mawji, N. R., Li, Z., Wang, J., Yang, Y. C., Imamura, Y., Yan, L., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734475 · Cited by 61 · see citing works
Self-citationMeehan, K. L., & Sadar, M. D. (2004) · PROTEOMICS · doi:10.1002/pmic.200300649 · Cited by 61 · see citing works
Self-citationJenster, G. W. (2000) · The Journal of Pathology · doi:10.1002/1096-9896(200007)191:3 · Cited by 61 · see citing works
Bellezza, I., Neuwirt, H., Nemes, C., Cavarretta, I. T. R., Puhr, M., Steiner, H., Minelli, A., Bartsch, G. C., Offner, F. A., Hobisch, A., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060171 · Cited by 59 · see citing works
Adam, R. M., Kim, J., Lin, J., Anna Orsola, A., Zhuang, L., Rice, D. C., & Freeman, M. R. (2002) · Endocrinology · doi:10.1210/en.2002-220561 · Cited by 56 · see citing works
- Authors
- Sadar, M. D.
- Affiliations
- BC Cancer Agency (CA)
- Corresponding author
- Sadar, Marianne D.
- ORCID
- Sadar, Marianne D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 274
- Issue
- 12
- Pages
- 7777-7783
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2043236550
- Cited by
- 270
- References
- 46
- Citations by year
- 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 4 · 2014: 2 · 2013: 10 · 2012: 10
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50dk047656-07)
- National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK47656)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- prostate-specific antigen, androgen receptor, protein kinase A, prostate cancer, forskolin, bicalutamide, androgen response element, LNCaP cells, PC-3 cells, transcriptional activation
- MeSH terms
- Androgen Antagonists, Androgens, Anilides, Colforsin, Humans, Nitriles, Receptors, Androgen, RNA, Messenger, Tosyl Compounds, Tumor Cells, Cultured, Signal Transduction, Gene Expression Regulation, Neoplastic, Prostate-Specific Antigen, Cyclic AMP-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review